Drawing for ESTROCET

USPTO serial 75189288

ESTROCET

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
COFIELD, JULIA
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ESTROCET?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

PHILIPPE BENNETT

PHILIPPE BENNETT BRYAN CAVE245 PARK AVENEW YORK, NY 10167UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceuticals, namely, conjugated estrogen tablets for use during menopauseABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 15, 1997ABN5ABANDONMENT - AFTER PUBLICATION—
Aug 13, 1997ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jul 15, 1997PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 13, 1997NPUBNOTICE OF PUBLICATION—
May 9, 1997CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 9, 1997DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance